Valeant Plans to Ask Lenders for Looser Terms on Debt Pact

Updated on
  • ‘Cushion’ not as large as company would like, CEO Papa says
  • Drugmaker remains in compliance with maintenance covenants

Valeant Shares Surge on Guidance Despite Profit Drop

Valeant Pharmaceuticals International Inc. plans to ask lenders to loosen restrictions on its debt load shortly, Chief Executive Officer Joe Papa said Tuesday on a call discussing second-quarter results.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.